Beth Israel Deaconess Medical Center (BIDMC) is a renowned teaching hospital of Harvard Medical School located in Boston, Massachusetts. It is part of the larger Beth Israel Lahey Health system, which was formed through the merger of Beth Israel Deaconess Medical Center and Lahey Health in 2019. BIDMC is known for its exemplary patient care, extensive biomedical research, and comprehensive teaching programs. The hospital offers a wide range of services, including a major trauma center, a birth center, and specialized facilities for cancer treatment, cardiology, and neurology. It also plays a vital role in medical research, contributing to advancements in various fields such as cancer biology, regenerative medicine, and genetics.
The findings have the potential to pave the way for new disease-modifying treatments for patients with Parkinson’s disease. A study published in Nature Communications by…
Discoveries may pave the way for improved therapies for gastrointestinal issues. Following your gut. Losing your appetite. A gutsy move. Though we often consider the…
A recent multi-country analysis of the average pregnancy length and timing of birth in the US, England, and the Netherlands suggests that the US could…
A study discovered a connection between elections and sleep, alcohol consumption, and general public mood. Major societal and political events can have a significant influence on…
Scientists emphasize the value of neurological follow-up in recovered individuals. It’s true that COVID-19 is primarily a respiratory disease. However, neurological symptoms have been described…
A comprehensive review of the scientific literature reveals that immunological, metabolic, and depression-related pathways are the most often reported disease mechanisms. Alzheimer’s disease affects almost…
Findings can help ease supply constraints. N95 respirators are commonly used in hospitals worldwide to protect healthcare personnel from infectious pathogens. During the COVID-19 pandemic,…
One-third of clinical trial participants who received no vaccine reported systemic adverse advents like headache and fatigue. A meta-analysis of COVID-19 vaccine trials revealed that…
Strong antibody response to mRNA vaccines declined over an eight-month follow-up period; lower initial response to single-shot Ad26 vaccine remained stable over time, research shows….
Massachusetts statewide study showed no significant differences in COVID-19 case rates between K-12 districts that implemented 3-feet versus 6-feet of physical distancing. As COVID-19 infection…
Study conducted at BIDMC is among the first to compare the impact of COVID-19 on patients and hospital resources versus the impact of influenza. In…
The increase in deaths occurred in states that were hit earliest by the pandemic — with the exception of Massachusetts. As the number of COVID-19…
New metrics and forecasting models are key to understanding and anticipating the challenges of the COVID-19 pandemic. The COVID-19 pandemic has fundamentally disrupted U.S. healthcare…
Findings lay groundwork for clinical development program. The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A…
Companion study suggests COVID-19 infection protects against re-exposure. With nearly 5 million confirmed cases globally and more than 300,000 deaths from COVID-19, much remains unknown…
HMS researchers at Beth Israel Deaconess Medical Center examined the current literature on the safety and efficacy of selective serotonin reuptake inhibitor (SSRI) use…
New research from scientists at Beth Israel Deaconess Medical Center provides key insights into the basic biology of tumor formation and offers a potential new…